KIA
Kopp Investment Advisors Portfolio holdings
AUM
$54.4M
This Quarter Return
-1.92%
1 Year Return
+14.33%
3 Year Return
+109.21%
5 Year Return
+340.79%
10 Year Return
–
AUM
$218M
AUM Growth
+$218M
(-8.7%)
Cap. Flow
-$2.43M
Cap. Flow
% of AUM
-1.12%
Top 10 Holdings %
Top 10 Hldgs %
57.55%
Holding
77
New
10
Increased
16
Reduced
40
Closed
7
Top Buys
| 1 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
$5.7M |
| 2 |
Supernus Pharmaceuticals
SUPN
|
$5.46M |
| 3 |
ENZ
Enzo Biochem, Inc.
ENZ
|
$2.48M |
| 4 |
Insulet
PODD
|
$2.25M |
| 5 |
STAAR Surgical
STAA
|
$1.82M |
Top Sells
| 1 |
Viavi Solutions
VIAV
|
$3.18M |
| 2 |
SPNC
Spectranetics Corp
SPNC
|
$2.92M |
| 3 |
ALU
ALCATEL-LUCENT ADR
ALU
|
$2.92M |
| 4 |
Omnicell
OMCL
|
$2.73M |
| 5 |
AKRX
Akorn, Inc.
AKRX
|
$2.29M |
Sector Composition
| 1 | Technology | 38.15% |
| 2 | Healthcare | 28.23% |
| 3 | Consumer Staples | 5.31% |
| 4 | Financials | 1.88% |
| 5 | Consumer Discretionary | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Aflac
AFL
$57.1B
| $900K | 0.41% |
14,466
-195
| -1% | -$12.1K |
|
52
SPDR S&P 500 ETF Trust
SPY
$656B
| $900K | 0.41% |
4,600
| – | – |
|
53
Exxon Mobil
XOM
$477B
| $897K | 0.41% |
8,909
-79
| -0.9% | -$7.95K |
|
54
NOV
NOV
$4.82B
| $889K | 0.41% |
10,795
-10
| -0.1% | -$97.8K |
|
55
T Rowe Price
TROW
$23.2B
| $889K | 0.41% |
+10,535
| New | +$889K |
|
56
IBM
IBM
$227B
| $837K | 0.38% |
4,620
-12
| -0.3% | -$2.08K |
|
|
GIMO
57
DELISTED
Gigamon Inc.
GIMO
| $771K | 0.35% |
+40,270
| New | +$771K |
|
58
Commault Systems
CVLT
$7.96B
| $705K | 0.32% |
+14,340
| New | +$705K |
|
59
Vanguard Total Stock Market ETF
VTI
$524B
| $397K | 0.18% |
3,900
| – | – |
|
60
Vanguard Short-Term Corporate Bond ETF
VCSH
$35.3B
| $281K | 0.13% |
3,500
+500
| +17% | +$40.1K |
|
61
Invesco QQQ Trust
QQQ
$364B
| $254K | 0.12% |
2,700
| – | – |
|
|
NXTM
62
DELISTED
NxStage Medical Inc.
NXTM
| $251K | 0.12% |
17,490
-1,860
| -10% | -$26.7K |
|
63
Alkermes
ALKS
$4.95B
| $250K | 0.11% |
4,959
+110
| +2% | +$5.55K |
|
|
NPSP
64
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $217K | 0.1% |
+6,570
| New | +$217K |
|
|
MSLI
65
DELISTED
Merus Labs International Inc.
MSLI
| $206K | 0.09% |
+93,485
| New | +$206K |
|
66
Intel
INTC
$105B
| $204K | 0.09% |
+6,614
| New | +$204K |
|
|
AVDL
67
Avadel Pharmaceuticals
AVDL
$1.42B
| $166K | 0.08% |
+11,034
| New | +$166K |
|
|
PMCS
68
DELISTED
P M C SIERRA INC
PMCS
| $152K | 0.07% |
20,000
| – | – |
|
69
LeMaitre Vascular
LMAT
$2.14B
| $123K | 0.06% |
14,848
+400
| +3% | +$3.31K |
|
70
Alphatec Holdings
ATEC
$2.35B
| $116K | 0.05% |
71,060
+1,915
| +3% | +$3.13K |
|
71
Blackrock
BLK
$170B
| – | – |
-3,520
| Closed | -$1.11M |
|
72
Cytokinetics
CYTK
$5.98B
| – | – |
-10,197
| Closed | -$97K |
|
73
Regeneron Pharmaceuticals
REGN
$59.8B
| – | – |
-4,451
| Closed | -$1.34M |
|
|
74
Viavi Solutions
VIAV
$2.57B
| – | – |
-227,263
| Closed | -$3.18M |
|
|
SPNC
75
DELISTED
Spectranetics Corp
SPNC
| – | – |
-96,420
| Closed | -$2.92M |
|